Re:Cognition Health achieves global quality standard for clinical research
NEWS - 22ND FEBRUARY 2023
Cognitive healthcare provider’s network of eight clinical trial sites achieves GCSA accredited status in seven key operational areas
Re:Cognition Health, the HSMA cognitive healthcare provider, has undergone a rigorous evidence-based assessment of its clinical research operations. Provided by Global Clinical Site Accreditation (GCSA), which provides an independent report on the quality, efficiency and effectiveness of current operational processes, the resulting accreditation offers reassurance to sponsors, contract research organisations, staff and patients that trial sites have been independently assessed against robust quality standards.
Re:Cognition Health has eight centres in the UK and USA, where it carries out international trials of disease-modifying and symptomatic drugs for Alzheimer’s disease and other neurological conditions. This network achieved the GCSA quality standard in all seven of the categories that are covered by the assessment: workforce quality accreditation; patient engagement; feasibility; study start-up & initiation; study management & closedown; R&D business strategy; and governance
“We take what we do very seriously because of the impact our trials can have on our patients and their families,” said Vicky Eyre, Re:Cognition Health’s clinical operations director. “We wanted to ensure we were providing the best quality service, while also developing our team. Through the GCSA accreditation process, we have been able to demonstrate best practices and processes.”
Jacqueline Johnson North, co-founder of GCSA, added: “The Re:Cognition Health staff were extremely enthusiastic and responsive to the GCSA process, demonstrating the deep-rooted commitment within the organisation to ensure they are working to the highest industry standards,” explained “The team were honest and open which enabled us to get a true picture of the clinical trials operational processes and the challenges involved, showing there is an incredibly positive attitude overall within the company to perform the trials to the best of everyone’s capabilities.”
-
FEATURE
An expert guide to gastroesophageal reflux disease
Dr James East of Mayo Clinic Healthcare on the causes, symptoms and potential complications of a common digestive disorder
-
FEATURE
The future of cancer services
Ahead of World Cancer Day 2023, three consultants from The Royal Marsden Private Care at Cavendish Square discuss the latest research and innovations
-
NEWS
HSMA cognitive health clinic teams up with data analytics experts
Re:Cognition Health is collaborating with MYndspan, a scanning and analytics company, to offer patients data-led insights into brain health
-
FEATURE
Historic breakthrough announced by Alzheimer’s researchers
Dr Emer MacSweeney of Re:Cognition Health on a major development in the fight against Alzheimer’s and the role played by her clinic in the search for new medications